Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (18)

« Back to Publications

Redefining the topology of the human bone marrow using augmented spatial transcriptomic analysis

Cooper RA. et al, (2025)

Reticulin-Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications.

Ryou H. et al, (2025), EJHaem, 6

Spatial transcriptomic approaches for characterising the bone marrow landscape: pitfalls and potential.

Cooper RA. et al, (2025), Leukemia, 39, 291 - 295

Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination.

Watson RA. et al, (2024), J Immunother Cancer, 12

Cytomegalovirus infection protects against metastatic melanoma and modulates oncological outcome and toxicity to checkpoint immunotherapy

Milotay G. et al, (2024)

Peripheral monocyte transcriptomics associated with immune checkpoint blockade outcomes in metastatic melanoma

Cooper R. et al, (2024)

Impact of the transition to digital pathology in a clinical setting on histopathologists in training: experiences and perceived challenges within a UK training region.

Browning L. et al, (2023), J Clin Pathol, 76, 712 - 718

Deep sequencing of the T cell Receptor reveals common and reproducible CD8+signatures of response to checkpoint immunotherapy

Watson R. et al, (2023)

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma.

Taylor CA. et al, (2022), Nat Med, 28, 2592 - 2600

Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunity.

Gilchrist JJ. et al, (2022), Nat Commun, 13

Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size and cytotoxicity.

Watson RA. et al, (2021), Sci Immunol, 6

Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles.

Ye W. et al, (2021), Br J Cancer, 124, 1661 - 1669

Counting Intraepithelial Lymphocytes: A Comparison Between Routine Staining and CD3 Immunohistochemistry.

Cooper R. et al, (2020), Int J Surg Pathol, 28, 367 - 370

novel stratification framework for predicting outcome in patients with prostate cancer.

Luca B-A. et al, (2020), Br J Cancer, 122, 1467 - 1476

Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma.

Fairfax BP. et al, (2020), Nat Med, 26, 193 - 199

Load More